Maculaser Ltd
Announced 07 Aug 2026$5.1M · Manufacturing · Finland
Maculaser develops novel medical technology for treatment of common retinal diseases, including dry Age-related Macular Degeneration.
“August was another impressive month for LSI Alumni companies, with 19 transactions totaling more than $156M.Here’s your #LSIAlumni transaction update for August:MaxQ Medical —Amir Tehrani→ Raised $31.5M Series A to advance its prostate ultrasound imaging and therapy platform.Lupin Dental —Paul Roberts→ Raised €15M Series A to advance its robotic de”
2 more sources tracked. Read the full press release and reporter coverage.
Sign up to read →